Content Status

Type

Linked Node

  • Management of DR-TB ADR: Gynecomastia

    Learning Objectives
    • Discuss Gynecomastia as an ADR to DR-TB Treatment, suspected agent(s).
    • Enumerate suggested management strategies for Gynecomastia.
H5Content
Content

Figure: Gynaecomastia due to Ethionamide treatment

Adverse Drug Reactions (ADRs), such as gynaecomastia, may occur from the Drug-resistant TB (DR-TB) treatment regimen.

 

 

Suspected agent(s): Ethionamide (Eto)

 

 

 

 

Suggested Management Strategies

 

  • Breast enlargement can be a troublesome side effect of Ethionamide (Eto) treatment, especially for male patients. Galactorrhea has also been reported.
  • Encourage patients to tolerate this side effect.

 

Points to Note

 

  • Resolution occurs after treatment is stopped.

 

Resources

 

 

Kindly provide your valuable feedback on the page to the link provided HERE

 

Content Creator

Reviewer


Linked Approval Requests

No content linked currently.